Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Lamivudine/zidovudine
print preview
bookmark
share with colleague
General Information
Company
Mylan Inc.
Description
Fixed dose combination of 2 nucleoside analog reverse transcriptase inhibitors
Molecular Target
Mechanism of Action
Latest Stage of Development
Marketed
Indication
HIV / AIDS
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information